Abstract-The concentration (10-8-10-5 M)-dependent contractile response of norepinephrine was completely inhibited by cyclooxygenase inhibitors but not by a thromboxane synthetase inhibitor. The amount of prostaglandin F2a was sig nificantly increased in the presence of norepinephrine (10-5 M). Norepinephrine increased the amount of prostaglandin D2, although not significantly. The norepi nephrine-evoked prostaglandin release was inhibited by tolazoline (3x10-5 M). These results suggest that norepinephrine evoked the release of prostaglandins, mainly prostaglandin F2a to induce the contraction of the guinea pig trachea.
Since Takagi et al. (1) reported the exist ence of alpha and beta types of adrenoceptors in guinea pig tracheal smooth muscles, it is generally accepted that the tracheal muscles contain alpha-adrenoceptors in addition to beta2-adrenoceptors (2) . Very recently, Takayanagi et al. (3) reported that the alpha adrenoceptors in the guinea pig tracheal muscle are the alpha2 type. The relaxation of trachea mediated through beta2-adre noceptors is well-documented. Little, how ever, is known about alpha-adrenoceptor mechanisms in the guinea pig trachea.
Male Hartley strain guinea pigs (6 weeks old and 330±8.3 g in body weight) were killed, and the trachea was isolated and cut open longitudinally. Epithelial cells were removed by 20 gentle rubbings of the luminal surface with a cotton probe (4, 5). The tracheal strips were prepared by the method of Takagi and Takayanagi (6) and suspended in a 20-ml organ bath filled with a physio logical solution (154 mM NaCI, 5.6 mM KCI, 2.2 mM CaCl2, 2.1 MM MgCl2, 5.9 MM NaHCO3 and 2.8 mM glucose) kept at 32'C and gassed with a mixture of 95% 02 and 5% CO2. This solution contained ascorbic acid (10-3 M), desmethylimipramine (10-7 M), corticosterone (3X10-5 M) and pargyline (10-5M) to inhibit the oxidation and neuronal and extraneuronal uptakes of norepinephrine and monoamine oxidase. To block beta adrenoceptors, the solution also contained propranolol (3X10-6 M). The preparation was connected via a thin thread to an isotonic transducer under a tension of 0.5 g for recording of the response. To test for antag onism, one antagonist was added to the bath 10 min before the addition of an agonist.
After removal of the epithelial cells from the opened trachea, the trachea was cut transversely between the segments of car tilage. Strips were incubated in the physio logical solution kept at 32 °C and gassed with a mixture of 95% 02 and 5% CO2 for 1 hr, and then divided into 2 groups. The groups were separately incubated in 900 ,aI of the physiological solution containing the inhibitors mentioned above (an incubation medium) for 10 min. The incubation medium was kept at 32'C and gassed with a mixture of 95% 02 and 5% CO2. One hundred microliters of norepinephrine, 10-4 M, was added to one group of strips, so that the final concentration of norepinephrine in the incu bation medium was 10-6 M. The other group was used as a control,-and 100 uI of the physiological solution was added instead of norepinephrine. Each group was thereafter incubated at 32°C for 10 min.
The antagonism between norepinephrine and tolazoline was tested in other experi ments. After incubation in the physiological solution, tracheal strips were divided into 2 groups, and separately incubated in 900 ,eI of the incubation medium kept at 32°C and gassed with a mixture of 95%02 and 5% CO2 as above. Tolazoline (at a final concentration of 3x10-5 M) was added to one group but not to the other. One hundred microliters of norepinephrine, 10-4 M, was then added to both groups; the final concentration of norepinephrine was 10-5 M. Both groups were incubated at 32 °C for 10 min. Fifty microliters of flurbiprofen, 10-4 M, was added to 50 ,ul of the incubation medium to inhibit the prostaglandin generation. These procedures were carried out at 0°C. Then, prostaglandins F2a and D2 in 100 ucl of the incubation medium were measured by radio immunoassay. Assay was done with a prostaglandin F2a [3H] assay kit (TRK 900) and a prostaglandin D2 [3H] assay kit (TRK 890), which were obtained commercially from Amersham. The strips used were blotted on filter paper (No. 2, Toyo-Roshi) and weighed.
The concentration contractile response curve of norepinephrine, which ranged between 10-8 and 10-5 M, was completely inhibited by the cyclooxygenase inhibitors indomethacin (10-5 M) and flurbiprofen (3 X 10-6 M), but not by a thromboxane syn thetase inhibitor, OKY-1581 (3X10-6 M) (3). Moreover, the resting basal tone in the guinea pig trachea was completely inhibited by indomethacin or flurbiprofen (7, 8).
The amount of prostaglandin F2a was significantly (P<0.05) increased by the 10 min incubation of strips with norepinephrine (10-5 M), but not with norepinephrine (10-8 M). When the strips were preincubated in the incubation medium containing tolazoline (3X10-5 M), which abolished the con tractile response to norepinephrine (10-5 M) (4), norepinephrine-evoked release of pros taglandin F2a was inhibited (Fig. 1) . The 10 min incubation of strips with norepinephrine (10-5 M) slightly (though not significantly) increased the release of prostaglandin D2. However, the 10-min preincubation with tolazoline (3x10-5 M) inhibited the release of prostaglandin D2 (Fig. 2) . The releases of prostaglandins F2a and D2 were completely prevented by treatment with indomethacin or flurbiprofen (data not shown), as previously The contractile response to norepinephrine was abolished by cyclooxygenase inhibitors but not by a thromboxane synthetase inhibitor, suggesting that the release of prostaglandins causes the guinea pig trachea contraction in the presence of norepinephrine.
Therefore, prostaglandins F2a and D2 were considered candidates for excitatory prostaglandins in the tracheal muscles. In the presence of 10-5 M of norepinephrine, which is the concen tration inducing maximum contraction (17.8 ±2.8% to isotonic 70 mM KCI), the amount of prostaglandin F2a was significantly in creased. The norepinephrine-evoked release of prostaglandin F2a was inhibited by tolazo line (3x10-5 M). Prostaglandin F2a is a major excitatory prostaglandin produced by the guinea pig trachea in resting (7, 8) and stimulated (7, 9) states.
In conclusion, norepinephrine interacts with alpha2-adre noceptors (3) and evokes the release of prostaglandins, mainly prostaglandin F2a, thus inducing contraction of the guinea pig trachea.
